SOURCE: Protherics PLC

July 02, 2008 05:31 ET

Protherics PLC announces Total Voting Rights

CHESHIRE, UK--(Marketwire - July 2, 2008) -


Protherics PLC


Total Voting Rights and Share Capital



London, UK; Brentwood, TN; 2 July 2008 - In conformity with the
Transparency Directive, Protherics PLC ("Protherics"), the
international biopharmaceutical company focused on critical care and
cancer, notifies the market of the following:


Protherics' issued share capital consists of
340,417,123 ordinary shares with a nominal value of 2 pence each, with
voting rights. Protherics does not hold any ordinary shares in
Treasury.  Therefore, the total number of voting rights
in Protherics is 340,417,123.


The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest
in, Protherics under the Financial Services Authority's Disclosure and
Transparency Rules.



/ Ends /
For further information please contact:


Protherics

Nick Staples, Director of Corporate Affairs   +44 (0) 7919 480510

Julie Vickers, Company Secretary              +44 (0)1928 518010


Financial Dynamics - press enquiries

London: Ben Atwell, Lara Mott                 +44 (0) 20 7831 3113

New York: John Capodanno, Jonathan Birt       +1 212 850 5600



Or visit  www.protherics.com

                    This information is provided by RNS
          The company news service from the London Stock Exchange

END

Contact Information